ReviewWorld journal of microbiology & biotechnology2022
Pseudomonas in environmental bioremediation of hydrocarbons and phenolic compounds- key catabolic degradation enzymes and new analytical platforms for comprehensive investigation.
Review in World journal of microbiology & biotechnology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed, 86 citations in OpenAlex.
- Bacteria-nanoplastic interactions: mechanisms, ecological consequences, and advances in biodegradation technologies.Archives of microbiology · 2026Review
- From screening to sequencing: Investigating the monoethylene glycol (MEG) biodegradation byBiotechnology reports (Amsterdam, Netherlands) · 2026Article
- Bio-degradational potential of genus Ochrobactrum.Biodegradation · 2026Review
- Assessment and functional genomic investigation of methane and nitrogen metabolizing pathways in Pseudomonas aeruginosa strain AAK/M5.World journal of microbiology & biotechnology · 2026Article
- Pan-Genomic and Phenotypic Characterisation of Petroleum Hydrocarbon Degradation by Pseudomonas Species.Environmental microbiology reports · 2026Review
- Biotransformation of Aliphatic and Aromatic Hydrocarbons by Aerobic Bacterial Strains Isolated from Brown Coal.International journal of molecular sciences · 2026Article
- Pseudomonas eutrophicaquae sp. nov., a novel xenobiotic-degrading non-motile bacterium, containing Q-8 ubiquinone, isolated from an aquatic ecosystem in Jimo District, China.Antonie van Leeuwenhoek · 2026Article
- Microbial engineering for pesticide degradation: current insights and future directions for sustainable agriculture.Frontiers in microbiology · 2026Review
- Biotechnological Prospects of Indigenous Oil-Degrading Bacteria for Engine Oil Remediation and Environmental Restoration in Mekelle, Ethiopia.TheScientificWorldJournal · 2026Article
- Microbial Community Succession During Bioremediation of Petroleum-Contaminated Soils UsingMicroorganisms · 2025Article
- Plastic-Microbial BioRemediation DB: A Curated Database for Multi-Omics Applications.Environmental microbiology reports · 2025Article
- Harnessing Microbial Power for a Sustainable Future Food System.Microorganisms · 2025Review
- Transcriptomic profiling ofMicrobial genomics · 2025Article
- Analysis of metagenomic data.Nature reviews. Methods primers · 2025Article
- Bioremediation of Polycyclic Aromatic Hydrocarbons by Means of Bacteria and Bacterial Enzymes.Microorganisms · 2024Review
- Article
- Metabolic Changes inMetabolites · 2024Article
- Inactivation of Pseudomonas putida KT2440 pyruvate dehydrogenase relieves catabolite repression and improves the usefulness of this strain for degrading aromatic compounds.Microbial biotechnology · 2024Article
- Aerobic phenol degradation using native bacterial consortium via ortho-and meta-cleavage pathways.Frontiers in microbiology · 2024Article
- Insights into polyethylene biodegradative fingerprint ofFrontiers in bioengineering and biotechnology · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pollution of the environment with petroleum hydrocarbons and phenolic compounds is one of the biggest problems in the age of industrialization and high technology. Species of the genus Pseudomonas, present in almost all hydrocarbon-contaminated areas, play a particular role in biodegradation of these xenobiotics, as the genus has the potential to decompose various hydrocarbons and phenolic compounds, using them as its only source of carbon. Plasticity of carbon metabolism is one of the adaptive strategies used by Pseudomonas to survive exposure to toxic organic compounds, so a good knowledge of its mechanisms of degradation enables the development of new strategies for the treatment of pollutants in the environment. The capacity of microorganisms to metabolize aromatic compounds has contributed to the evolutionally conserved oxygenases. Regardless of the differences in structure and complexity between mono- and polycyclic aromatic hydrocarbons, all these compounds are thermodynamically stable and chemically inert, so for their decomposition, ring activation by oxygenases is crucial. Genus Pseudomonas uses several upper and lower metabolic pathways to transform and degrade hydrocarbons, phenolic compounds, and petroleum hydrocarbons. Data obtained from newly developed omics analytical platforms have enormous potential not only to facilitate our understanding of processes at the molecular level but also enable us to instigate and monitor complex biodegradations by Pseudomonas. Biotechnological application of aromatic metabolic pathways in Pseudomonas to bioremediation of environments polluted with crude oil, biovalorization of lignin for production of bioplastics, biofuel, and bio-based chemicals, as well as Pseudomonas-assisted phytoremediation are also considered.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.